 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/12/2024 |
$31.98 |
$31.98 |
$30.08 |
$30.24 |
375.00K | | 04/15/2024 |
$30.51 |
$30.60 |
$29.68 |
$29.99 |
372.70K | | 04/16/2024 |
$30.00 |
$30.40 |
$29.35 |
$29.43 |
388.90K | | 04/17/2024 |
$29.74 |
$30.08 |
$28.88 |
$29.00 |
393.80K | | 04/18/2024 |
$28.87 |
$29.48 |
$28.63 |
$28.87 |
347.90K |
|
|
| Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. Co.'s products include Trokendi XR and Oxtellar XR, which are the once-daily extended release topiramate and oxcarbazepine products indicated for the treatment of epilepsy; APOKYN, which is a product indicated for the intermittent treatment of hypomobility or off episodes in patients with Parkinson's Disease (PD); XADAGO, which is an once-daily product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD; and MYOBLOC, which is a product indicated for the treatment of cervical dystonia and sialorrhea in adults. | |
|
Supernus Pharmaceuticals (SUPN) has the following price history information. Looking back at SUPN historical stock prices for the last five trading days, on April 12, 2024, SUPN opened at $31.98, traded as high as $31.98 and as low as $30.08, and closed at $30.24. Trading volume was a total of 375.00K shares. On April 15, 2024, SUPN opened at $30.51, traded as high as $30.60 and as low as $29.68, and closed at $29.99. Trading volume was a total of 372.70K shares. On April 16, 2024, SUPN opened at $30.00, traded as high as $30.40 and as low as $29.35, and closed at $29.43. Trading volume was a total of 388.90K shares. On April 17, 2024, SUPN opened at $29.74, traded as high as $30.08 and as low as $28.88, and closed at $29.00. Trading volume was a total of 393.80K shares. On April 18, 2024, SUPN opened at $28.87, traded as high as $29.48 and as low as $28.63, and closed at $28.87. Trading volume was a total of 347.90K shares.
SUPN Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Supernus Pharmaceuticals shares, starting with a $10,000 purchase of SUPN, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$8.38 |
|
| End price/share: |
$28.87 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
244.51% |
|
| Average Annual Total Return: |
13.17% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$34,448.15 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/12/2024 | $30.24 | | 04/15/2024 | $29.99 | | 04/16/2024 | $29.43 | | 04/17/2024 | $29.00 | | 04/18/2024 | $28.87 |
|
|
Free SUPN Email Alerts:
